about
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literatureALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitorsAACR Cancer Progress Report 2014Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.ALK-driven tumors and targeted therapy: focus on crizotinibPredictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern.Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations.A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.Pathobiology of T-cell and NK-cell lymphomas.Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.ALK-positive anaplastic large cell lymphoma presenting as intradural spinal mass: first reported case and review of literature.Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate.Anaplastic large cell lymphoma in children and adolescents.ALK Positive Anaplastic Large Cell Lymphoma With Pure Leptomeningeal Involvement: Unique Case Report and Review of the Literature.Peripheral T cell lymphoma in Asia.To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive LymphomasCrizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of ALK-Positive Anaplastic Large Cell Lymphoma.Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report.Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experienceExpression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature.Atypical blood and bone marrow lymphocytes in ALK-positive anaplastic T-cell lymphoma: important lessons.TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.Three Years Sustained Complete Remission Achieved in a Primary Refractory ALK-Positive Anaplastic T Large Cell Lymphoma Treated with Crizotinib.ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2.Beyond B-cell lymphomas: a case of optic nerve anaplastic large cell lymphoma in a HIV positive patient.DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation.Remission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy.Violet - Colored Inguinal Located Cutaneous Tumour?Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.Refractory ALK-Positive Anaplastic Large Cell Lymphoma: Long Term Survival with Crizotinib
P2860
Q26862702-8BA19254-B7D8-4A3C-8E9C-5B469D77A0F1Q27310990-53289517-55C3-4219-92CE-9F4F7160D163Q27346723-5510FCD4-78F1-4A5C-B625-2DDB46C4B6CBQ34401878-775DEFC8-5CE2-4107-8A7E-535FD6A7CDB4Q34414378-0B344401-5573-483A-8C31-898C313E0EF1Q34620545-E83D2860-2DB3-49C2-8B24-027A082B3497Q35013574-AC06DA44-7C55-4222-A22F-A80AD1DD7194Q35038644-584C80AE-2D47-4D8D-8519-45ED08B26B61Q35697053-A1A9C194-876E-44E9-866B-43F2A54806A6Q36893709-AB9D7652-A0E1-4B55-9440-8C82AEB5A77AQ37033993-06BD68C7-68A5-41D6-A229-4A16AB3BB475Q37350788-F71EE29D-384E-4F0A-97F8-F4AB16C6D00CQ38053452-6571195D-15F8-4EE3-A98E-A761E9225DF4Q38073207-0F417065-FBEB-4814-A033-26556E3CD36AQ38113829-6025D49C-F471-4C20-A604-282E591B11EDQ38177195-6F0CCCFE-0BFE-4531-9A8C-1EA30D02821CQ38183756-2E1447C4-FF44-41EF-B0BC-5E402EA479B7Q38536210-95C15FFC-DBAA-432A-834F-7FA6DA19F743Q38644718-FE9AC95E-3C83-442C-AFDE-C036899AF67EQ38698187-B67E8E2F-F4DB-44FD-BCE4-C62FDCFF8E1EQ38865125-75D5A3B6-9E4C-4CAC-8E7E-999699FD8052Q38947647-61FC532C-95B7-4EE4-86C7-E310AAFAD67AQ38949798-505C060F-44C2-42C8-AF71-01862C587888Q38962008-BFF7487E-BE5D-428F-B2AB-E62153727464Q39261912-29B0BC45-1008-48B4-B2DE-9CA9E7AEE158Q40234517-EE1DA1C0-E937-471E-B2BD-F368A4AD3C21Q41133791-193EC6D1-3369-45C8-AE00-717A13C59D57Q42429703-D7F47A46-1340-4711-85C2-E4E024DB21B0Q42943366-1527B8C9-8DA4-4C34-A18E-5C3699B8304FQ43632789-596ED4DD-5C8B-4BD0-BDAF-95E68335C6BCQ44610536-94B1DADC-7CEC-4A74-8DB8-8AD605F14DF8Q45729167-253CC2D4-C3A3-4ED7-9300-B89CEA5D10EEQ48202591-45A94C71-A06F-4CC1-BC8F-FC2C4A7AFCADQ51609725-804995BF-3C31-42E5-BFCE-B118C8F1EA98Q52985914-AB9F3E8C-8D73-4AED-A42B-D1B9444565B8Q55040675-8FA9F0CE-16BD-4283-904A-01A2A8193A1FQ55057314-14844B74-637C-449C-BD8B-64A13B5FD4E3Q56524606-4698038E-CAB8-4A6D-9788-6D53D4B8BAD8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anaplastic large cell lymphoma, ALK-positive.
@en
Anaplastic large cell lymphoma, ALK-positive.
@nl
type
label
Anaplastic large cell lymphoma, ALK-positive.
@en
Anaplastic large cell lymphoma, ALK-positive.
@nl
prefLabel
Anaplastic large cell lymphoma, ALK-positive.
@en
Anaplastic large cell lymphoma, ALK-positive.
@nl
P2093
P1476
Anaplastic large cell lymphoma, ALK-positive.
@en
P2093
Andrés J M Ferreri
Kerry J Savage
Silvia Govi
Stefano A Pileri
P304
P356
10.1016/J.CRITREVONC.2012.02.005
P577
2012-03-21T00:00:00Z